🇺🇸 Salmeterol MDI in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anger — 1 report (10%)
  2. Asthenia — 1 report (10%)
  3. Atrophy — 1 report (10%)
  4. Dysstasia — 1 report (10%)
  5. Excitability — 1 report (10%)
  6. Guillain-Barre Syndrome — 1 report (10%)
  7. Incontinence — 1 report (10%)
  8. Movement Disorder — 1 report (10%)
  9. Neuropathy Peripheral — 1 report (10%)
  10. Palatal Oedema — 1 report (10%)

Source database →

Other Respiratory approved in United States

Frequently asked questions

Is Salmeterol MDI approved in United States?

Salmeterol MDI does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Salmeterol MDI in United States?

Sumitomo Pharma America, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.